Publications

You can use the filters to show only results that match your interests

181 publications by Advisory Council on the Misuse of Drugs ×

Get updates to this list email feed

Copy and paste this URL in to your feed reader

1. Further advice on scheduling of cannabis-derived medicinal products

   • 11 September 2018
   • ACMD
   • Correspondence

2. ACMD members' register of interests

   • 3 August 2018
   • ACMD
   • Corporate report

3. Advice on scheduling of cannabis-derived medicinal products

   • 19 July 2018
   • ACMD
   • Correspondence

4. Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

   • 3 July 2018
   • Home Office and ACMD
   • Guidance

5. Legitimate use of controlled drugs: research and healthcare

   • 24 May 2018
   • ACMD
   • Correspondence

6. Letter requesting evidence: custody-community transitions

   • 8 May 2018
   • ACMD
   • Correspondence

7. Advice on amending the Misuse of Drugs (Safe Custody) Regulations 1973

   • 2 May 2018
   • ACMD
   • Correspondence

8. Prescribing of controlled drugs by therapeutic radiographers: further advice

   • 2 May 2018
   • ACMD
   • Correspondence

9. ACMD work programme for 2017 to 2019

   • 28 March 2018
   • ACMD
   • Correspondence

10. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • 4 December 2017
    • ACMD
    • Correspondence

11. Commissioning impact on drug treatment

    • 6 September 2017
    • ACMD
    • Corporate report

12. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • 20 July 2017
    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
    • Corporate report

13. Drug strategy 2016: development review

    • 14 July 2017
    • ACMD
    • Corporate report

14. Psychoactive Substances Bill: evaluation review

    • 14 July 2017
    • ACMD
    • Corporate report

15. Methiopropamine: a review of the evidence of use and harm

    • 16 June 2017
    • ACMD
    • Corporate report

16. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • 23 March 2017
    • ACMD
    • Policy paper

17. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • 10 March 2017
    • Home Office and ACMD
    • Correspondence

18. Advice on U-47,700, etizolam and other designer benzodiazepines

    • 21 December 2016
    • ACMD
    • Correspondence

19. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • 21 December 2016
    • ACMD
    • Correspondence

20. Misuse of Drugs Regulations 2001: impact on research

    • 16 December 2016
    • ACMD
    • Correspondence

21. Plant cannabinoids: ACMD report

    • 16 December 2016
    • ACMD
    • Policy paper

22. Diversion & illicit supply of medicines

    • 15 December 2016
    • ACMD
    • Policy paper

23. Reducing opioid-related deaths in the UK

    • 12 December 2016
    • ACMD
    • Independent report

24. 'Third generation' synthetic cannabinoids

    • 15 November 2016
    • ACMD
    • Correspondence

25. Temporary class drug order on methiopropamine

    • 30 September 2016
    • ACMD
    • Correspondence

26. Problems for Ageing Drug Users Working Group: public meeting invitation

    • 9 September 2016
    • ACMD
    • Promotional material

27. Independent prescribing of controlled drugs by therapeutic radiographers

    • 5 September 2016
    • ACMD
    • Correspondence

28. ACMD work programme for 2016

    • 27 April 2016
    • ACMD
    • Correspondence

29. ACMD review of alkyl nitrites (poppers)

    • 16 March 2016
    • ACMD
    • Correspondence

30. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • 14 January 2016
    • ACMD
    • Correspondence

31. Advice on the steroid Dienedione

    • 14 January 2016
    • ACMD
    • Correspondence

32. ACMD’s temporary class drug order report on Methiopropamine

    • 26 November 2015
    • ACMD
    • Correspondence

33. ACMD public meeting: 24 November 2015

    • 17 November 2015
    • ACMD
    • Form

34. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • 23 October 2015
    • ACMD
    • Correspondence

35. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • 23 October 2015
    • ACMD
    • Policy paper

36. Ministerial response to ACMD report on cocaine misuse

    • 17 September 2015
    • DHSC, Home Office and ACMD
    • Correspondence

37. Ministerial response to ACMD report on nitrous oxide misuse

    • 17 September 2015
    • DHSC, Home Office and ACMD
    • Correspondence

38. ACMD interim advice: diversion and illicit supply of medicines

    • 27 August 2015
    • ACMD
    • Correspondence

39. ACMD report on definitions for the Psychoactive Substances Bill

    • 17 August 2015
    • ACMD
    • Correspondence

40. ACMD advice about Northern Ireland’s continued maintenance of the Addicts Index

    • 17 August 2015
    • ACMD
    • Correspondence